Spiro derivatives of parthenin as novel anticancer agents
The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SAWANT SANGHAPAL DAMODHAR QAZI NAVEED AHMED DOMA MAHENDHAR REDDY HALMUTHUR MAHABALARAO SAMPATH KUMAR SINGH SHASHANK KUMAR BANDAY ABID HUSSAIN QAZI GHULARN NABI SETHI VIJAY KUMAR TANEJA SUBHASH CHANDRA SAXENA AJIT KUMAR VERMA MONIKA |
| description | The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (alpha-methylene-gamma-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 muM to 93 muM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the alpha,beta-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8609858B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8609858B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8609858B23</originalsourceid><addsrcrecordid>eNqNyjEKAjEQBdA0FqLeYS4gLIqSbRUX-9V6GeJfHVgmITPk_DYewOo1bx36sUjN9EKVxi4NRnmmwtU_UFFiI80NC7G6JNaESvyGum3DaubFsPu5CTTcHtf7HiVPsMIJCp-eYzx3fTzFy-H4R_kCCdUuzQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Spiro derivatives of parthenin as novel anticancer agents</title><source>esp@cenet</source><creator>SAWANT SANGHAPAL DAMODHAR ; QAZI NAVEED AHMED ; DOMA MAHENDHAR REDDY ; HALMUTHUR MAHABALARAO SAMPATH KUMAR ; SINGH SHASHANK KUMAR ; BANDAY ABID HUSSAIN ; QAZI GHULARN NABI ; SETHI VIJAY KUMAR ; TANEJA SUBHASH CHANDRA ; SAXENA AJIT KUMAR ; VERMA MONIKA</creator><creatorcontrib>SAWANT SANGHAPAL DAMODHAR ; QAZI NAVEED AHMED ; DOMA MAHENDHAR REDDY ; HALMUTHUR MAHABALARAO SAMPATH KUMAR ; SINGH SHASHANK KUMAR ; BANDAY ABID HUSSAIN ; QAZI GHULARN NABI ; SETHI VIJAY KUMAR ; TANEJA SUBHASH CHANDRA ; SAXENA AJIT KUMAR ; VERMA MONIKA</creatorcontrib><description>The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (alpha-methylene-gamma-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 muM to 93 muM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the alpha,beta-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131217&DB=EPODOC&CC=US&NR=8609858B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131217&DB=EPODOC&CC=US&NR=8609858B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAWANT SANGHAPAL DAMODHAR</creatorcontrib><creatorcontrib>QAZI NAVEED AHMED</creatorcontrib><creatorcontrib>DOMA MAHENDHAR REDDY</creatorcontrib><creatorcontrib>HALMUTHUR MAHABALARAO SAMPATH KUMAR</creatorcontrib><creatorcontrib>SINGH SHASHANK KUMAR</creatorcontrib><creatorcontrib>BANDAY ABID HUSSAIN</creatorcontrib><creatorcontrib>QAZI GHULARN NABI</creatorcontrib><creatorcontrib>SETHI VIJAY KUMAR</creatorcontrib><creatorcontrib>TANEJA SUBHASH CHANDRA</creatorcontrib><creatorcontrib>SAXENA AJIT KUMAR</creatorcontrib><creatorcontrib>VERMA MONIKA</creatorcontrib><title>Spiro derivatives of parthenin as novel anticancer agents</title><description>The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (alpha-methylene-gamma-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 muM to 93 muM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the alpha,beta-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKAjEQBdA0FqLeYS4gLIqSbRUX-9V6GeJfHVgmITPk_DYewOo1bx36sUjN9EKVxi4NRnmmwtU_UFFiI80NC7G6JNaESvyGum3DaubFsPu5CTTcHtf7HiVPsMIJCp-eYzx3fTzFy-H4R_kCCdUuzQ</recordid><startdate>20131217</startdate><enddate>20131217</enddate><creator>SAWANT SANGHAPAL DAMODHAR</creator><creator>QAZI NAVEED AHMED</creator><creator>DOMA MAHENDHAR REDDY</creator><creator>HALMUTHUR MAHABALARAO SAMPATH KUMAR</creator><creator>SINGH SHASHANK KUMAR</creator><creator>BANDAY ABID HUSSAIN</creator><creator>QAZI GHULARN NABI</creator><creator>SETHI VIJAY KUMAR</creator><creator>TANEJA SUBHASH CHANDRA</creator><creator>SAXENA AJIT KUMAR</creator><creator>VERMA MONIKA</creator><scope>EVB</scope></search><sort><creationdate>20131217</creationdate><title>Spiro derivatives of parthenin as novel anticancer agents</title><author>SAWANT SANGHAPAL DAMODHAR ; QAZI NAVEED AHMED ; DOMA MAHENDHAR REDDY ; HALMUTHUR MAHABALARAO SAMPATH KUMAR ; SINGH SHASHANK KUMAR ; BANDAY ABID HUSSAIN ; QAZI GHULARN NABI ; SETHI VIJAY KUMAR ; TANEJA SUBHASH CHANDRA ; SAXENA AJIT KUMAR ; VERMA MONIKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8609858B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SAWANT SANGHAPAL DAMODHAR</creatorcontrib><creatorcontrib>QAZI NAVEED AHMED</creatorcontrib><creatorcontrib>DOMA MAHENDHAR REDDY</creatorcontrib><creatorcontrib>HALMUTHUR MAHABALARAO SAMPATH KUMAR</creatorcontrib><creatorcontrib>SINGH SHASHANK KUMAR</creatorcontrib><creatorcontrib>BANDAY ABID HUSSAIN</creatorcontrib><creatorcontrib>QAZI GHULARN NABI</creatorcontrib><creatorcontrib>SETHI VIJAY KUMAR</creatorcontrib><creatorcontrib>TANEJA SUBHASH CHANDRA</creatorcontrib><creatorcontrib>SAXENA AJIT KUMAR</creatorcontrib><creatorcontrib>VERMA MONIKA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAWANT SANGHAPAL DAMODHAR</au><au>QAZI NAVEED AHMED</au><au>DOMA MAHENDHAR REDDY</au><au>HALMUTHUR MAHABALARAO SAMPATH KUMAR</au><au>SINGH SHASHANK KUMAR</au><au>BANDAY ABID HUSSAIN</au><au>QAZI GHULARN NABI</au><au>SETHI VIJAY KUMAR</au><au>TANEJA SUBHASH CHANDRA</au><au>SAXENA AJIT KUMAR</au><au>VERMA MONIKA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Spiro derivatives of parthenin as novel anticancer agents</title><date>2013-12-17</date><risdate>2013</risdate><abstract>The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (alpha-methylene-gamma-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 muM to 93 muM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the alpha,beta-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8609858B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | Spiro derivatives of parthenin as novel anticancer agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T10%3A09%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAWANT%20SANGHAPAL%20DAMODHAR&rft.date=2013-12-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8609858B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |